Morpho’s Itemiser DX Trace Detector Approved for Air Cargo Screening in Canada
High-performance, user-friendly detector identifies a broad range of explosives in seconds. WILMINGTON, Mass. – October 1, 2014 - Morpho (Safran), through its subsidiary Morpho Detection, today announced the desktop Itemiser® DX explosives trace detector (ETD) has been qualified by Transport Canada for air cargo screening. As a result of this approval, the seventh by a global regulatory agency, Itemiser DX is now available for the quick, accurate detection of explosives at air cargo facilities throughout Canada. The government department responsible for developing transportation security procedures, Transport Canada maintains a Qualified Equipment and Services List to help industry maintain compliance with Canada's air cargo security regulations. "We are pleased that Transport Canada has recognized the ability of Itemiser DX to help air cargo companies enhance explosives screening capabilities," said Karen Bomba, president and CEO, Morpho Detection. "By quickly and accurately detecting explosives, Itemiser DX helps air cargo companies meet current and emerging security challenges with minimal impact on commerce." A lightweight, portable desktop system, more than 5,000 Itemiser DX units have been shipped to air cargo screening facilities, airports, critical infrastructure and secure locations around the world.
Morpho Detection, part of Morpho, Safran's (PAR: SAF) security business, is a leading supplier of explosives and narcotics and chemical, radiological, and nuclear detection systems for government, military, air and ground transportation, first responder, critical infrastructure and other high-risk organizations. Morpho Detection integrates computed tomography, Raman spectroscopy, trace (ITMS™), mass spectrometry, X-ray and X-ray Diffraction technologies into solutions that can make security activities more accurate, productive and efficient. Morpho Detection's solutions are deployed to help protect people and property the world over. For more information:
Follow @safran_morpho on Twitter